S

Seaport Therapeutics

Develops orally bioavailable antidepressants and anxiolytics

Director, Clinical Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBoston, MA, USA$198k - $225kHybrid

About the Job

Requirements

  • A bachelor's degree and 12 or more years of related experience, preferably in life sciences, with 8 or more years in Clinical Quality Assurance; alternatively, an equivalent combination of pharmacovigilance and quality assurance experience.
  • Deep knowledge of global regulations, including FDA and EMA regulations, and guidelines including ICH, GVP, and GxP, including safety reporting requirements.
  • Broad clinical development experience across all phases, from Phase I through BLA/NDA.
  • Strong understanding of GCP quality principles spanning preclinical, clinical, and commercial stages.
  • Proven experience developing and implementing risk-based clinical quality assurance programs.
  • Demonstrated success leading clinical site and supplier audits, managing regulatory inspections, and responding to findings.
  • Ability to effectively communicate quality events and outcomes to internal stakeholders.
  • Excellent interpersonal, verbal, and written communication skills.
  • Ability to set clear objectives, manage competing priorities, and meet dynamic timelines.
  • Flexible and creative problem-solving ability with a proactive mindset.
  • Willingness to travel up to 20% based on business needs.

Responsibilities

  • Lead GCP compliance and quality oversight for clinical programs.
  • Develop and implement risk-based quality strategies.
  • Inform and contribute to audit planning and strategy.
  • Perform and/or coordinate clinical site and vendor audits.
  • Oversee deviations, quality issues, corrective and preventive actions (CAPAs), effectiveness checks, root cause analyses, and associated key performance indicators.
  • Advise internal stakeholders and external partners on GCP compliance matters and identify emerging non-compliance trends.
  • Support inspection readiness activities and co-host regulatory inspections.
  • Develop and deliver GCP-related training, and contribute to creating, revising, and maintaining policies, standard operating procedures, and work instructions in alignment with global regulatory requirements.
  • Conduct and/or manage qualification and oversight of service providers.
  • Ensure service providers adhere to quality programs and applicable regulations and maintain inspection readiness.
  • Assess and escalate compliance risks identified through audits to protect subject safety, data integrity, and business continuity.
  • Lead or support preparation for and response to regulatory audits and inspections, ensuring adherence to requirements and timely resolution of findings.
  • Support investigational new drug applications and related correspondence with global regulatory authorities.
  • Perform other duties as assigned.

Desired Qualifications

  • Working knowledge of multiple therapeutic areas.
  • Life sciences experience is preferred.

About the Company

Seaport Therapeutics

Develops orally bioavailable antidepressants and anxiolytics

Seaport Therapeutics develops new antidepressants and anxiolytics for neuropsychiatric disorders. Its products are designed to be orally bioavailable and to avoid first-pass metabolism while minimizing hepatotoxicity and other side effects. The company advances drug candidates through clinical trials and regulatory approval with the aim of commercialization, either directly or via partnerships and licensing with larger pharmaceutical companies. The team combines biotech industry experience to support development and execution. Unlike some peers, Seaport focuses on PK properties that improve oral bioavailability and safety, aiming for drugs that patients can take easily and with fewer liver-related risks. The overarching goal is to bring safe, effective neuropsychiatric medications to patients by progressing through development to market, leveraging partnerships to scale.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Seaport Therapeutics

See more jobs